Mercado de implantes corneales: crecimiento, tendencias, impacto de COVID-19 y pronósticos (2023 - 2028)

El mercado mundial de implantes de córnea está segmentado por tipo (córnea humana y córnea artificial), tipo de procedimiento (queratoplastia endotelial, queratoplastia penetrante y otros tipos de procedimientos), indicación de enfermedad (queratocono, distrofia de Fuchs, queratitis infecciosa, úlceras corneales y otras indicaciones de enfermedad). ), Usuario final (Hospitales, Centros quirúrgicos ambulatorios y Centros oftálmicos) y Geografía (América del Norte, Europa, Asia-Pacífico y Resto del mundo). El informe ofrece el valor (en millones de USD) para los segmentos anteriores.

Instantánea del mercado

corneal implants market share
Study Period: 2018-2026
Fastest Growing Market: Asia-Pacific
Largest Market: North America
CAGR: > 6 %

Major Players

corneal implants market major players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Visión general del mercado

The corneal implants market is projected to register a CAGR of more than 6% over the forecast period.

The rapid emergence of the COVID-19 pandemic has had a significant impact on ophthalmic surgeries across the globe. The suspension of elective procedures during the pandemic reduced the number of patients undergoing ophthalmic surgery, globally, as ophthalmic procedures are considered elective procedures. In March 2020, the Centers for Medicare & Medicaid Services (CMS) recommended the cancellation of elective surgery as a part of the national response to COVID-19. Moreover, in March 2020, the American Academy of Ophthalmology (AAO) released practice guidelines advising ophthalmologists to cease providing any treatment other than urgent and emergent care. Moreover, in November 2020, Eye Bank Associations (EBAA) and the Global Alliance of Eye Bank Associations (GAEBA) recommended guidelines to exclude infected donors. The introduction of such guidelines has impacted the number of ophthalmic surgeries being performed in the pandemic. However, as the lockdown restrictions are reducing, the number of ophthalmic procedures performed worldwide will eventually increase and thus boost the market in the forecast period.

The studied market growth can be largely attributed to the factors such as technological advancements in corneal implants, the increasing prevalence of the geriatric population, and growing incidences of eye disorders worldwide. These factors are leading to a huge demand for corneal implants in the healthcare facilities.

Technological advancements in corneal implants is contributing to the market growth. Significant advancements are being taken place to develop cost-effective corneal implants with improved safety and efficacy. In January 2019, the United States Food and Drug Administration (USFDA) approved a new Boston KPro model, Boston keratoprosthesis, Moreover, the demand for collagen-based artificial corneas is increasing owing to their biocompatibility and low cost that has led to development of bio-engineered artificial corneas. For instance, LinkCor, developed by Life Sciences AB, commercially available in 2020, is anticipated to be a potential substitute for human corneas. Furthermore, CorNeat Vision has developed an easily implantable and affordable artificial cornea, CorNeat KPro. The CorNeat KPro has been designed to replace scarred, deformed or opacified corneas and is anticipated to fully and immediately rehabilitate the vision of corneally blind patients. The product is expected to achieve the CE marking and FDA clearance in 2022. Thus, the aforementioned technological developments are contributing to the rising demand for corneal implants.

Increasing prevalence of geriatric population is anticipated to increase the demand for corneal implants. Corneal implants are used in keratoplasty procedures such as penetrating and endothelial keratoplasty. The geriatric population is prone to suffer from Fuchs’ dystrophy which is treated by endothelial keratoplasty (EK). According to a 2020 published article by the National Library of Medicine (NLM), the late-onset form of Fuchs’ endothelial dystrophy is a common condition, affecting approximately 4 percent of people above 40 years of age in the United States. In addition, bullous keratopathy is the most common condition among older people that undergo cataract surgery. Such patients are recommended to undergo endothelial keratoplasty (EK) procedure. Moreover, as per the World Population Ageing 2019 report by the United Nations (UN), globally, the number of people aged 80 years or older nearly tripled between 54 million in 1990 to 143 million in 2019 and is anticipated to triple again between 2019 and 2050 to reach 426 million by 2050. Thus, the increase in prevalence of geriatric population will fuel the overall market growth.

Also, due to the growing incidences of eye disorders worldwide, there is a huge demand for corneal implants. The corneal implants are used in the treatment of keratoconus, corneal opacity, corneal blindness and other eye disorders. As per the 2020 statistics by the Cornea Research Foundation of America, 50 to 200 out of every 100,000 people in the general population are affected with keratoconus disorder. This indicates that increase in number of people suffering with keratoconus disorder indicate will increase the demand for corneal implants. In addition, as per the 2020 statistics by the Royal National Institute of Blind People (RNIB), an estimated number of 4.1 million people in the United Kingdom will be affected by blindness by 2050. Furthermore, as per the 2021 statistics by the World Health Organization (WHO), globally, approximately, 2.2 billion people have a near or distant vision impairment, including 4.2 million people having corneal opacities. Such a huge number indicates a high demand for corneal implants. Thus, all the above-mentioned factors are currently augmenting the growth of the corneal implants market.

However, high costs of surgical procedures and ophthalmic devices and availability of alternative treatments are some of the factors impeding the market growth.

Alcance del Informe

Según el alcance del informe, el implante corneal es la incorporación de tejido de córnea de donante humano o córnea artificial para reemplazar la córnea enferma del ojo mediante queratoplastia lamelar anterior, queratoplastia endotelial, queratoplastia penetrante, queratoprótesis y queratoprótesis. Están diseñados para la visión a largo plazo y se utilizan principalmente para el tratamiento de trastornos oftálmicos como la distrofia de Fuchs y el queratocono, entre otros trastornos. El mercado de implantes de córnea está segmentado por tipo (córnea humana y córnea artificial), tipo de procedimiento (queratoplastia endotelial, queratoplastia penetrante y otros tipos de procedimientos), indicación de enfermedad (queratocono, distrofia de Fuchs, queratitis infecciosa, úlceras corneales y otras indicaciones de enfermedad) , Usuario final (Hospitales, Centros quirúrgicos ambulatorios y Centros oftálmicos) y Geografía (América del Norte, Europa, Asia-Pacífico y Resto del Mundo). El informe de mercado también cubre los tamaños y tendencias de mercado estimados para diferentes países en las principales regiones, a nivel mundial. El informe ofrece el valor (en millones de USD) para los segmentos anteriores.

By Implant Type
Artificial Corneal Implant
Human Corneal Implant
By Procedure Type
Endothelial Kertoplasty
Penetrating Keratoplasty
Others
By Disease Indication
Keratoconus
Fuschs' Dystrophy
Infectious Keratitis
Corneal Ulcers
Other Disease Indications
By End-User
Hospitals
Ambulatory Surgical Centers
Ophthalmic Centers
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Rest of the World

Report scope can be customized per your requirements. Click here.

Tendencias clave del mercado

Se espera que la queratoplastia penetrante experimente un crecimiento significativo durante el período de pronóstico

Según el tipo de procedimiento, se prevé que la queratoplastia penetrante experimente un crecimiento significativo durante el período de pronóstico. Los factores principales debido al crecimiento de la queratoplastia penetrante son el número cada vez mayor de personas que sufren lesiones en el globo ocular y trastornos oculares. Los procedimientos de queratoplastia penetrante se realizan para tratar a pacientes que padecen trastornos oculares como úlceras corneales y queratitis infecciosa. Además, se prefiere la queratoplastia penetrante (PKP) para tratar la enfermedad corneal ectásica y ha sido el procedimiento estándar para el tratamiento de pacientes con queratocono con resultados ópticos y visuales notables para pacientes con queratocono que son intolerantes a las lentes de contacto o tienen agudeza visual corregida. Según el Informe estadístico de bancos de ojos de 2019 de la Asociación de bancos de ojos de América (EBAA), el uso doméstico de tejido de queratoplastia en los Estados Unidos ha llevado a un aumento en la cantidad de injertos penetrantes realizados de 17 347 en 2018 a 17 409 en 2019. Por lo tanto, el número creciente de procedimientos de queratoplastia penetrante realizados indica la creciente demanda de implantes de córnea. Por lo tanto, en vista de los factores mencionados anteriormente, se prevé que el segmento crezca significativamente durante el período de pronóstico.

corneal implants market trends

América del Norte representó la mayor participación en el mercado global

Dentro de América del Norte, Estados Unidos ha ocupado la mayor parte del mercado y se espera que domine el período de pronóstico. La creciente conciencia sobre la donación de ojos en la región y la presencia de varias organizaciones son algunos de los principales factores que explican el crecimiento del mercado en la región. La Asociación de Bancos de Ojos de América (EBAA) celebra el mes de la donación de ojos que se lleva a cabo cada noviembre para crear conciencia sobre la donación y el trasplante de córnea. Tales iniciativas aumentan el número de cirugías oculares realizadas en el país. Por ejemplo, según el Informe estadístico de bancos de ojos de 2019 de la Asociación de bancos de ojos de América (EBAA), la cantidad de procedimientos de queratoplastia endotelial aumentó un 1 % en 2019 a 30 650 de 30 336 en 2018. Además, Según las estadísticas de 2020 de los Centros para el Control y la Prevención de Enfermedades (CDC), aproximadamente 12 millones de personas de 40 años o más sufren problemas de visión en los Estados Unidos. Por lo tanto, el aumento de la prevalencia de la discapacidad visual en la región ha aumentado la cantidad de cirugías oftálmicas que contribuyen aún más a la creciente demanda de implantes de córnea. Por lo tanto, en vista de los factores mencionados anteriormente, el crecimiento del mercado se impulsará en América del Norte.

corneal implants market analysis

Panorama competitivo

El mercado de implantes de córnea está muy fragmentado debido a la presencia de varios actores del mercado regionales y globales. Estos jugadores se centran en estrategias de crecimiento, como lanzamientos de nuevos productos, innovaciones en productos existentes y fusiones y adquisiciones. Algunos de los actores del mercado también se están enfocando en la provisión de córneas de ojos humanos mientras mantienen un enfoque en las donaciones de ojos. Los actores clave del mercado que operan en el mercado global son CorneaGen, CorNeat Vision, Aurolab, KERAMED, INC. y Price Vision Group.

Principales actores

  1. CorneaGen

  2. CorNeat Vision

  3. Aurolab

  4. Price Vision Group

  5. KERAMED, INC.

*Disclaimer: Major Players sorted in no particular order

CorneaGen, CorNeat Vision, Aurolab, KERAMED, INC., Price Vision Group.

Recent Developments

In February 2019, CorneaGen announced acquiring KeraLink International domestic eye bank operations. The acquisition enabled the company to expand its footprint in the United States market to increase the company’s access to important discoveries in the treatment and prevention of corneal disease.

In September 2019, CorNeat announced completing preclinical stage of its corneal implant, CorNeat K-Pro and is awaiting the successful initiation and completion of clinical trials.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Technological Advancements in Corneal Implants

      2. 4.2.2 Increasing Prevalence of Geriatric Population

      3. 4.2.3 Growing Incidences of Eye Disorders

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Surgical Procedures and Ophthalmic Devices

      2. 4.3.2 Availability of Alternative Treatments

    4. 4.4 Porter’s Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Implant Type

      1. 5.1.1 Artificial Corneal Implant

      2. 5.1.2 Human Corneal Implant

    2. 5.2 By Procedure Type

      1. 5.2.1 Endothelial Kertoplasty

      2. 5.2.2 Penetrating Keratoplasty

      3. 5.2.3 Others

    3. 5.3 By Disease Indication

      1. 5.3.1 Keratoconus

      2. 5.3.2 Fuschs' Dystrophy

      3. 5.3.3 Infectious Keratitis

      4. 5.3.4 Corneal Ulcers

      5. 5.3.5 Other Disease Indications

    4. 5.4 By End-User

      1. 5.4.1 Hospitals

      2. 5.4.2 Ambulatory Surgical Centers

      3. 5.4.3 Ophthalmic Centers

    5. 5.5 Geography

      1. 5.5.1 North America

        1. 5.5.1.1 United States

        2. 5.5.1.2 Canada

        3. 5.5.1.3 Mexico

      2. 5.5.2 Europe

        1. 5.5.2.1 Germany

        2. 5.5.2.2 United Kingdom

        3. 5.5.2.3 France

        4. 5.5.2.4 Italy

        5. 5.5.2.5 Spain

        6. 5.5.2.6 Rest of Europe

      3. 5.5.3 Asia-Pacific

        1. 5.5.3.1 China

        2. 5.5.3.2 Japan

        3. 5.5.3.3 India

        4. 5.5.3.4 Australia

        5. 5.5.3.5 South Korea

        6. 5.5.3.6 Rest of Asia-Pacific

      4. 5.5.4 Rest of the World

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Florida Lions Eye Bank

      2. 6.1.2 CorNeat Vision

      3. 6.1.3 CorneaGen

      4. 6.1.4 San Diego Eye Bank

      5. 6.1.5 Alabama Eye Bank

      6. 6.1.6 Aurolab

      7. 6.1.7 Cornea Biosciences

      8. 6.1.8 KERAMED, INC.

      9. 6.1.9 Price Vision Group

      10. 6.1.10 LinkoCare LifeSciences AB

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

El Mercado de Implantes Corneales se estudia desde 2018 - 2028.

El mercado de implantes de córnea está creciendo a una CAGR del 6,1 % en los próximos 5 años.

Asia-Pacífico está creciendo a la CAGR más alta entre 2018 y 2028.

América del Norte tiene la participación más alta en 2021.

CorneaGen, CorNeat Vision, Aurolab, Price Vision Group, KERAMED, INC. son las principales empresas que operan en el mercado de implantes corneales.

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!